Position in ARGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$338,105
-$17,616 QoQ
Shares Held
463
+9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Smartleaf Asset Management LLC holds $9,124,817 across 150 Biotechnology names. ARGX ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,540 | $2,027,291 | |
| 2 | CAI |
Caris Life Sciences, Inc.
|
94,051 | $1,681,631 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846 | $653,653 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,361 | $450,314 | |
| 5 | ARGX |
Argenx SE
This page
|
463 | $338,105 | |
| 6 | ALLO |
Allogene Therapeutics, Inc.
|
137,874 | $336,412 | |
| 7 | INSM |
INSMED Inc
|
1,747 | $285,669 | |
| 8 | TECH |
BIO-TECHNE Corp
|
4,639 | $242,434 |
All Filings in ARGX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $338,105 | 463 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $355,721 | 423 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $281,747 | 382 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $141,663 | 257 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $187,029 | 316 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $167,280 | 272 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $48,245 | 89 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $16,341 | 38 | Shares | Sole | 2024-10-08 | |
| 2024-03-31 | $5,512 | 14 | Shares | Sole | 2024-10-07 | |
| 2023-12-31 | $4,565 | 12 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||